 | 
| | Tue Apr 1, 2008 Forbes Medi-Tech now Trading under former NASDAQ Trading Symbol 'FMTI'
|
| | Vancouver, Canada Forbes Medi-Tech Inc. (TSX: FMI and NASDAQ: FMTI), ("Forbes" or "Company") today announced that it has received confirmation that its interim trading symbol "FMTID" is now changed back to "FMTI" effective today, April 1, 2008. Beginning March 3, 2008, for a period of 20 trading days Forbes common stock was trading on a post-reverse split basis on the NASDAQ under the trading symbol "FMTID" - an interim symbol to denote its post reverse split status." The trading symbol for Forbes on the TSX ("FMI") remains unchanged.
About Forbes Medi-Tech Inc.
Forbes Medi-Tech Inc. is a life sciences company dedicated to the research, development and commercialization of innovative products for the prevention and treatment of life-threatening disease. Our strategy and vision is to develop and market a portfolio of products for the benefit of all consumers, from the healthy person desiring consumer lifestyle products that can help reduce the risk of future disease, to medical patients needing therapeutic prescription products for the treatment of an established ailment. Additional information on Forbes Medi-Tech can be found at www.forbesmedi.com
# # #
For more information, please contact:
Forbes Investor Relations
Telephone: (604) 681-8976
E-mail: ir@forbesmedi.com
NASDAQ and the Toronto Stock Exchange have not reviewed and do not accept responsibility for the adequacy or accuracy of the content of this News Release. This News Release contains forward-looking statements and information regarding the trading symbol for shares of Forbes Medi-Tech Inc. on Nasdaq, and Forbes' strategy and vision. Forward-looking statements and information can be identified by the use of forward-looking terminology such as "will", "strategy", "vision", "to develop" or comparable terminology referring to future events or results. Forward-looking statements and information are statements and information about the future and are inherently uncertain. The Company's actual achievements and other results and occurrences could differ materially from those anticipated in these forward-looking statements and information due to a variety of risks, uncertainties and other factors, including, without limitation, the fact that trading symbols are subject to change without notice; uncertainty about whether Forbes will regain compliance with Nasdaq's minimum bid price listing standard; by May 27, 2008, failing which the Company's shares may be delisted from The NASDAQ, uncertainty whether Forbes will be able to continue to maintain either its TSX or its Nasdaq listing; the need for additional funding in the near term, which may not be available in a timely manner or at all, and if not so obtained, will have a material adverse effect on Forbes; the risk of unanticipated costs or expenses; uncertainty whether the Company will realize is strategies and vision; changes in business strategy or development plans; as well as a description of other risks and uncertainties affecting the Company and its business, as contained in news releases and filings with the United States Securities and Exchange Commission and Canadian Securities Regulatory Authorities, any of which could cause actual results to vary materially from current results or the Company's anticipated future results. Forward-looking statements and information are based on the assumptions, beliefs, opinions and expectations of the Company's management at the time they are made, and, except as required by applicable law the Company does not assume any obligation to update its forward-looking statements or information if those assumptions, beliefs, opinions or expectations or other circumstances should change. |
| |
| | You can view the Next News Releases item: Thu Apr 24, 2008, Forbes Medi-Tech Announces Pharmavite Contract Renewal ~Following Strong Volume Growth in 2007, the Company Looks to Further Expand Product Line with Reducol(tm)-Based Products~
You can view the Previous News Releases item: Mon Mar 31, 2008, Forbes Medi-Tech announces Financial Results for the Year ended December 31, 2007
You can return to the main News Releases page, or press the Back button on your browser.
|
|  |  |